Plexus (PLXS) 47th Annual Raymond James Institutional Investor Conference summary
Event summary combining transcript, slides, and related documents.
47th Annual Raymond James Institutional Investor Conference summary
2 Mar, 2026Company overview and market focus
Designs, manufactures, and services complex electronic and electromechanical products for healthcare, industrial, and aerospace/defense sectors.
Healthcare products often meet Class II and III regulatory requirements, including robotic-assisted surgery systems.
Industrial segment is driven by semiconductor capital equipment, industrial automation, and energy management.
Aerospace and defense focus on commercial aerospace, defense guidance, unmanned systems, and commercial space.
Targets annual revenue growth of 9%-12%, operating margin of 6%+, and 15% ROIC.
Market trends and growth drivers
Recent years saw flat growth, but current momentum is strong due to ramping programs and new wins.
Semiconductor capital equipment and commercial space are experiencing robust growth.
Healthcare and defense markets show positive trends, while industrial remains mixed.
Commercial aerospace recovery could provide further upside.
Growth is occurring even as not all market sectors are fully recovered.
Capacity expansion and supply chain strategy
Recent investments include a new facility in Penang, Malaysia, and expansion in Thailand.
New Penang site reached break-even quickly and can scale to $1 billion in capacity.
Manufacturing footprint supports growth to $5–6 billion revenue, with focus on expanding existing locations.
Nearshoring and regional supply chain strategies help manage uncertainty and customer needs.
Latest events from Plexus
- Board elections, compensation, and auditor ratification passed amid strong financial and ESG results.PLXS
AGM 202618 Feb 2026 - Q1 2026 revenue up 10% YoY, non-GAAP EPS $1.78, and robust sector wins support raised outlook.PLXS
Q1 20265 Feb 2026 - Q3 2024 exceeded expectations with strong cash flow, margin gains, and a positive growth outlook.PLXS
Q3 20242 Feb 2026 - Strong growth, cash flow focus, and sector resilience position the company for FY25 margin targets.PLXS
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Record free cash flow and margin gains set stage for robust EPS growth in fiscal 2025.PLXS
Q4 202418 Jan 2026 - Q1 2025 EPS and cash flow beat guidance as sector wins drive a strong outlook.PLXS
Q1 20259 Jan 2026 - Strong margins, robust cash flow, and global capacity drive growth in complex product markets.PLXS
Raymond James 46th Annual Institutional Investors Conference29 Dec 2025 - Q2 2025 delivered strong revenue, margin, and cash flow, with robust Q3 growth outlook.PLXS
Q2 202524 Dec 2025 - Annual meeting to elect directors, approve pay, ratify auditors, and review strong ESG and governance.PLXS
Proxy Filing22 Dec 2025